Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

NCT ID: NCT06472817

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-05

Study Completion Date

2026-09-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done to understand what social factors affect health decisions for those who have immigrated from another country by examining how the immigration from Sub-Sahara Africa affects the experiences of participants regarding health-seeking behaviors, care, and treatment of prostate cancer. It also examines similarities and differences among participants based on their region of origin in Africa.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVE:

I. To employ the social determinant of migrant health framework (International Organization for Migration, n.d.) to examine the impact of immigration on the health-seeking behaviors of SSAI including informed-decision making, psychosocial effects and coping mechanisms. (Phase I) II. To examine SDOMH factors among SSAI and CI men, including their migration experience and health behaviors. (Phase II)

OUTLINE: This is an observational study.

AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study.

AIM II: Participants complete an interview in person, over the phone, or via zoom on study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational

AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study.

AIM II: Participants complete an interview in person, over the phone, or via zoom on study.

Non-Interventional Study

Intervention Type OTHER

Non-interventional study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Interventional Study

Non-interventional study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PHASE I:

* Adult men originally from each of these geographic regions (East, West, Central, and Southern Africa) and have been diagnosed with prostate cancer
* Able to provide written consent and conduct an interview
* Able to speak and understand English
* PHASE II:

* Caribbean Immigrant men and SSAI men diagnosed with CaP within the last 10 years who identify as Black and speak English
* Able to provide written consent and conduct an interview
* Able to speak and understand English

Exclusion Criteria

* PHASE I:

* Patients below the ages of 18, and those not belonging to any of four regions
* Employees of Mayo Clinic will be excluded
* Non-English speakers will not be included
* PHASE II:

* Individuals below the age of 18
* Those not diagnosed with prostate cancer and individuals not from the regions described above
* Employees of Mayo Clinic will be excluded
* Non-English speakers will not be included
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Congressionally Directed Medical Research Programs

FED

Sponsor Role collaborator

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gladys B. Asiedu, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic in Rochester

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Georgia State University

Atlanta, Georgia, United States

Site Status

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2024-03996

Identifier Type: REGISTRY

Identifier Source: secondary_id

17109

Identifier Type: OTHER

Identifier Source: secondary_id

22-005329

Identifier Type: OTHER

Identifier Source: secondary_id

W81XWH-22-1-0971

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

22-005329

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Partnership for Healthy Seniors
NCT00379743 COMPLETED NA
CommunityRx-Cardiovascular Disease
NCT06264726 ACTIVE_NOT_RECRUITING NA
Cancer PRevention Through Enhanced EnvironMenT
NCT06864260 ACTIVE_NOT_RECRUITING NA